Genmed, Inc.

Genmed, Inc. specializes in two primary categories of medical devices: non-powdered vinyl examination and treatment gloves, which are used for clinical and medical procedures, and aneroid sphygmomanometers, which measure blood pressure in healthcare settings. These products are designed for direct patient care and monitoring.

Genmed, Inc. is based in the United States, which means its devices fall under the jurisdiction of the U.S. Food and Drug Administration (FDA). The FDA regulates medical devices in the U.S., and Genmed’s products are classified under FDA categories, including Class I and Class II, depending on their risk level and intended use.

Genmed, Inc.’s devices are listed in the FDA’s 510(k) registry, which documents premarket submissions for devices deemed substantially equivalent to predicate devices, and the FDA’s Unique Device Identification (UDI) system. These registries help track and verify the compliance and authorization status of specific devices.

Genmed, Inc.’s devices are classified under FDA’s Class I and Class II categories. Class I devices generally pose minimal risk and may require general controls, while Class II devices involve a higher risk and require special controls to ensure safety and effectiveness. The classification depends on the device’s purpose, such as gloves (often Class II due to infection control risks) and sphygmomanometers (typically Class II for blood pressure measurement accuracy).

The FDA’s 510(k) pathway applies to devices that are deemed substantially equivalent to a legally marketed predicate device—that is, they have the same intended use, technological characteristics, and risk profile. Genmed’s devices may follow this pathway if they meet these criteria, allowing the FDA to review them for compliance with regulatory requirements before market authorization. This pathway is common for devices like sphygmomanometers, where equivalence to existing products can streamline the authorization process.